Blueshift Asset Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-11,523
| Closed | -$162K | – | 837 |
|
|
2022
Q2 | $162K | Sell |
11,523
-1,529
| -12% | -$21.5K | 0.03% | 596 |
|
|
2022
Q1 | $187K | Buy |
+13,052
| New | +$187K | 0.02% | 742 |
|
|
2021
Q1 | – | Sell |
-23,680
| Closed | -$431K | – | 1067 |
|
|
2020
Q4 | $431K | Sell |
23,680
-25,401
| -52% | -$462K | 0.05% | 443 |
|
|
2020
Q3 | $876K | Buy |
+49,081
| New | +$876K | 0.12% | 233 |
|
|
2020
Q1 | – | Sell |
-71,217
| Closed | -$1.41M | – | 642 |
|
|
2019
Q4 | $1.41M | Buy |
+71,217
| New | +$1.41M | 0.16% | 195 |
|
|
2019
Q3 | – | Sell |
-33,232
| Closed | -$588K | – | 951 |
|
|
2019
Q2 | $588K | Sell |
33,232
-5,759
| -15% | -$102K | 0.08% | 369 |
|
|
2019
Q1 | $794K | Buy |
+38,991
| New | +$794K | 0.11% | 295 |
|